Cargando…
Glucagon‐like peptide‐1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesity
Precise control of blood glucose is dependent on adequate β‐cell mass and function. Thus, reductions in β‐cell mass and function lead to insufficient insulin production to meet demand, and result in diabetes. Recent evidence suggests that paracrine signaling in the islet might be important in obesit...
Autores principales: | Linnemann, Amelia K, Davis, Dawn Belt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854504/ https://www.ncbi.nlm.nih.gov/pubmed/27186355 http://dx.doi.org/10.1111/jdi.12465 |
Ejemplares similares
-
Glucagon‐like peptide‐1: The missing link in the metabolic clock?
por: Brubaker, Patricia L, et al.
Publicado: (2016) -
Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion
por: Reimann, Frank, et al.
Publicado: (2016) -
Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1
por: Seino, Yusuke, et al.
Publicado: (2016) -
Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
por: Katsurada, Kenichi, et al.
Publicado: (2016) -
Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals
por: Hirano, Tsutomu, et al.
Publicado: (2016)